Scalable intracellular delivery via microfluidic vortex shedding enhances the function of chimeric antigen receptor T-cells
Year: 2025
Type: article
Abstract: Adoptive chimeric antigen receptor T-cell (CAR-T) therapy is transformative and approved for hematologic malignancies. It is also being developed for the treatment of solid tumors, autoimmune disorders, heart disease, and aging. Despite unprecedented clinical outcomes, CAR-T and other engineered cell therapies face a variety of manufacturing and safety challenges. Traditional methods, such as lentivirus transduction and electroporation, result in random integration or cause significant cellular damage, which can limit the safety and efficacy of engineered cell therapies. We present hydroporation as a gentle and effective alternative for intracellular delivery. Hydroporation resulted in 1.7- to 2-fold higher CAR-T yields compared to electroporation with superior cell viability and recovery. Hydroporated cells exhibited rapid proliferation, robust target cell lysis, and increased pro-inflammatory and regulatory cytokine secretion in addition to improved CAR-T yield by day 5 post-transfection. We demonstrate that scaled-up hydroporation can process 5 × 10 8 cells in less than 10 s, showcasing the platform as a viable solution for high-yield CAR-T manufacturing with the potential for improved therapeutic outcomes.
Source: Scientific Reports
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funders: National Science Foundation, U.S. Department of Health and Human Services, Pioneer Fund, Cancer Prevention and Research Institute of Texas, Amazon Web Services, National Institutes of Health, University of California, San Francisco, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources
Awards: G1306916804, BD Biosciences Special Order LSRII, G2859315832, G3102002109, G4756830717, G5336074028, G5351157054, Rapid, single-step precision engineering and pre-clinical evaluation of chimeric antigen receptor Regulatory T cells for Type 1 diabetes, G5526576063, Advanced Multiparameter Cytometry and Cell Sorting Core, G7837447426, G8153776008, Diabetes Research Center, Dynamic single-cell analysis instrument to evaluate immune cell function, Baylor College of Medicine Cancer Center - Cancer Center Support Grant, Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
OpenAlex ID: W4407635164
